ANIX CIK: 715446

Anixa Biosciences Inc

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY23
millions USD
FY21:
0.13
FY22:
0
FY23:
0.05
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.1
FY22:
−13.9
FY23:
−11.0
FY24:
−13.8
FY25:
−11.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.1
FY22:
−13.8
FY23:
−11.0
FY24:
–
FY25:
−11.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.1
FY22:
−13.8
FY23:
−9.93
FY24:
–
FY25:
−11.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.0
FY22:
−13.6
FY23:
−9.81
FY24:
−12.6
FY25:
−10.9

All amounts in millions USD Data sources:SEC EDGARTwelve Data